Loading...
XKRX000640
Market cap457mUSD
Dec 26, Last price  
106,700.00KRW
1D
-0.84%
1Q
-11.67%
Jan 2017
-31.82%
Name

Dong-A Socio Holdings Co Ltd

Chart & Performance

D1W1MN
XKRX:000640 chart
P/E
11.50
P/S
0.59
EPS
9,277.25
Div Yield, %
1.87%
Shrs. gr., 5y
0.36%
Rev. gr., 5y
9.87%
Revenues
1.13t
+11.54%
686,809,156,000763,589,003,000866,234,795,000947,638,085,0001,055,699,080,2501,105,996,371,970570,870,106,640630,625,193,750704,734,520,020726,165,504,520690,264,581,710707,170,723,240769,685,605,090783,315,662,470881,944,084,0301,014,860,897,9501,132,002,860,400
Net income
57.99b
+640.12%
34,763,877,00043,375,193,00063,263,267,00071,482,696,00069,219,623,00085,877,512,60015,568,205,9101,715,985,59047,883,250,600149,051,293,02032,543,386,670-163,977,361,48019,764,497,050162,345,444,36060,270,881,3107,835,195,64057,989,523,140
CFO
158.70b
+109.16%
44,496,394,00063,530,432,00096,724,584,000144,600,127,000121,502,517,02055,724,205,08035,782,979,340-7,915,516,97080,936,807,40030,476,158,12084,456,509,83058,321,851,92096,786,624,59084,572,091,360131,087,231,09075,874,278,310158,697,909,560
Dividend
Jun 27, 2024700 KRW/sh
Earnings
Jan 30, 2025

Profile

Dong-A Socio Holdings Co., Ltd. engages in the pharmaceutical business in South Korea and internationally. It offers Bacchus, Benachio, and Tempo; infection management products; imaging equipment, such as FX-V1 and CLS-S7 for surgery and diagnosis; and MEDIFLIX, a medical knowledge-sharing platform. The company provides business management services; CMO services, including pre-clinical study, clinical trial, and commercial production of antibodies and recombinant proteins; maintenance, repair, and operation; quarantine; and military logistics services; and packaging and parcel delivery services. In addition, it offers mineral water under the Gayasan Cheonnyeonsu brand; POCARI SWEAT; Narangd cider; Oronamin C; Oran-C bio-PET; and STP2104, an mRNA based COVID-19 vaccine, which is in phase I clinical trial. Further, the company engages in the construction of industrial facilities, such as bio, pharmaceutical, food, logistics warehouses, education/research facilities, work/sales facilities, and public facilities; provides design, maintenance, and asset development services. Additionally, it provides IT systems development and maintenance. The company was founded in 1932 and is headquartered in Seoul, South Korea.
URL
http://www.donga.co.kr/
IPO date
Feb 10, 1970
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
1,132,002,860
11.54%
1,014,860,898
15.07%
881,944,084
12.59%
Cost of revenue
935,534,981
861,721,111
721,145,797
Unusual Expense (Income)
NOPBT
196,467,880
153,139,787
160,798,287
NOPBT Margin
17.36%
15.09%
18.23%
Operating Taxes
9,870,691
9,773,384
5,592,832
Tax Rate
5.02%
6.38%
3.48%
NOPAT
186,597,188
143,366,402
155,205,455
Net income
57,989,523
640.12%
7,835,196
-87.00%
60,270,881
-62.87%
Dividends
(12,501,446)
(9,375,974)
(9,181,346)
Dividend yield
1.98%
1.48%
1.29%
Proceeds from repurchase of equity
(83,111,315)
216,299,388
BB yield
13.10%
-30.43%
Debt
Debt current
420,088,777
409,783,530
324,172,023
Long-term debt
376,059,483
194,960,196
267,567,331
Deferred revenue
13,527,827
8,797,332
8,340,255
Other long-term liabilities
12,581,337
3,240,052
3,023,752
Net debt
21,058,775
(134,799,839)
(136,721,115)
Cash flow
Cash from operating activities
158,697,910
75,874,278
131,087,231
CAPEX
(150,114,314)
(78,600,552)
(78,731,176)
Cash from investing activities
(161,359,976)
(42,465,377)
(136,611,522)
Cash from financing activities
27,393,049
(38,001,749)
16,032,796
FCF
43,789,964
97,617,382
58,316,823
Balance
Cash
154,691,260
103,386,538
158,472,256
Long term investments
620,398,224
636,157,027
569,988,212
Excess cash
718,489,341
688,800,520
684,363,264
Stockholders' equity
787,586,066
759,936,395
745,479,580
Invested Capital
1,026,810,794
859,272,112
827,389,502
ROIC
19.79%
17.00%
20.20%
ROCE
11.24%
9.81%
10.54%
EV
Common stock shares outstanding
6,251
6,251
6,180
Price
101,000.00
-0.49%
101,500.00
-11.74%
115,000.00
-6.12%
Market cap
631,323,023
-0.49%
634,448,384
-10.73%
710,719,780
-4.49%
EV
667,219,917
642,957,155
721,802,950
EBITDA
270,638,789
223,873,164
220,172,327
EV/EBITDA
2.47
2.87
3.28
Interest
22,745,717
14,853,870
11,503,160
Interest/NOPBT
11.58%
9.70%
7.15%